Showing results (3981-3990 of 6,740) with videos related to

Sort By:
Pageof 674
Oncotargets and Therapy|November 30, 2016
A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolationHenrik Frithiof, Kristina Aaltonen, Lisa Rydén
Oncotargets and Therapy|November 30, 2016
Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cellsLisha Xie, Tiancen Zhao, Jing Cai, et al.
Oncotargets and Therapy|December 7, 2016
The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosisRun Zhai, Fang Tang, Jianhua Gong, et al.
Oncotargets and Therapy|December 7, 2016
Meta-analysis of the impact of thioprine S-methyltransferase polymorphisms on the tolerable 6-mercaptopurine dose considering initial dose and ethnic differenceMyeong Gyu Kim, Minoh Ko, In-Wha Kim, et al.
Oncotargets and Therapy|December 7, 2016
Monitoring the effects of doxorubicin on 3D-spheroid tumor cells in real-timeNamHuk Baek, Ok Won Seo, MinSung Kim, et al.
Oncotargets and Therapy|December 23, 2016
Biomarkers in pancreatic adenocarcinoma: current perspectivesDouglas S Swords, Matthew A Firpo, Courtney L Scaife, et al.
Oncotargets and Therapy|December 23, 2016
Correlation between epidermal growth factor receptor tyrosine kinase inhibitor efficacy and circulating tumor cell levels in patients with advanced non-small cell lung cancerWenjie He, Wenhui Li, Bo Jiang, et al.
Oncotargets and Therapy|December 23, 2016
β-Elemene treatment of glioblastoma: a single-center retrospective studyChunxiao Ma, Wei Zhou, Zhaoyue Yan, et al.
Oncotargets and Therapy|November 24, 2016
Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysisStefan-Alexandru Artene, Adina Turcu-Stiolica, Richard Hartley, et al.
Oncotargets and Therapy|November 24, 2016
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinomaVictor Jeannot, Benoit Busser, Laetitia Vanwonterghem, et al.
Pageof 674